NUMA1 and urinary bladder carcinoma: Three major biomarkers used in diagnosing and treating bladder cancer include Bladder Tumor Antigen (BTA) STAT, BTA TRAK, and Nuclear Matrix Protein 22 (NMP22) (1, 49).